ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ソタロール塩酸塩

Sotalol Hydrochloride

HCID 66245
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
959-24-0
標準SMILES
CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl
InChIKey
VIDRYROWYFWGSY-UHFFFAOYSA-N
分子式
C12H21ClN2O3S
平均分子量
308.83 g/mol

概要

Sotalol hydrochloride is a hydrochloride salt that is the monohydrochloride of sotalol. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. It has a role as a beta-adrenergic antagonist and an anti-arrhythmia drug. It contains a sotalol(1+).

名称と識別子

優先名称
Sotalol Hydrochloride
IUPAC
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
現地名
ソタロール塩酸塩
英語名
Sotalol hydrochloride
分子式
C12H20N2O3S.ClH
分子量
308.83

名称と別名

Sotalol hydrochloride959-24-0Sotalol HCLBetapaceBetapace AFSotacorSotalexSorineSotylizeBerlexMJ 1999Darob
名称をさらに表示
ソタレックスN-[4-[2-(イソプロピルアミノ)-1-ヒドロキシエチル]フェニル]メタンスルホンアミド·塩酸塩塩酸ソタロールソタコールベータカルドン塩酸塩ソタロール塩酸塩N-[4-[1-ヒドロキシ-2-(イソプロピルアミノ)エチル]フェニル]メタンスルホンアミド·塩酸塩(±)-ソタロール 塩酸塩ソタロール塩酸塩 (JAN)N-[4-[2-(イソプロピルアミノ)-1-ヒドロキシエチル]フェニル]メタンスルホンアミド・塩酸塩N-[4-[1-ヒドロキシ-2-(イソプロピルアミノ)エチル]フェニル]メタンスルホンアミド・塩酸塩MJ-1999DL-MJ 1999SOLATOL HCLmeadjohnson1999
Sotalol MonohydrochlorideHEC37C70XXIsopropylaminohydroxyethylmethanesulfonanilide hydrochloride4'-(1-Hydroxy-2-(isopropylamino)ethyl)methanesulfonanilide monohydrochlorideNSC-337251NSC-760358DTXSID8021278N-Isopropyl-beta-(4-methanesulfonamidophenyl)ethanolamine hydrochloride

データベース識別子

CAS
959-24-0
PubChem CID
66245
ChEMBL
CHEMBL1700
ChEBI
CHEBI:9207
UNII
HEC37C70XX
EC Number
213-496-0

物性

構造計算による物性

極性表面積
86.8 Ų
水素結合供与体数
4
水素結合受容体数
5
回転可能結合数
6
重原子数
19
形式電荷
0
複雑度
330

実験および物理化学的性質

Solubility>46.3 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Adrenergic Beta-Antagonists; Antiarrhythmics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section166.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
218 · 218-220°C
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: 20 mg/mL
外見
粉
色
ホワイトからオフホワイト
水溶解度
リン酸緩衝生理食塩水、DMSO、エタノール、水、メタノールに可溶。
主な用途
医薬品低分子化合物
InChI
InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H
InChIKey
VIDRYROWYFWGSY-UHFFFAOYSA-N
SMILES
C(C1C=CC(=CC=1)NS(=O)(=O)C)(O)CNC(C)C.Cl
CAS データベース
959 · 959-24-0(CAS DataBase Reference)

化学的性質

化学的特性White Crystalline Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 1.4% (1 of 73) of reports.

Warning

H315 (94.5%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 73 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Other Safety InformationIMAP assessments - Methanesulfonamide, N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]-, monohydrochloride: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (94.5%)

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Sotalol hydrochloride

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
3
rtecs
PB0826000
毒性
LD50 in male mice, rats (mg/kg): 2600, 3450 orally; 670, 680 i.p.; LD50 orally in rabbits: 1000 mg/kg; LD50 i.p. in dogs: 330 mg/kg (Lish)
hs_code
2935904000
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

FDA Pharmacological Classification · 6 件

SOTALOL HYDROCHLORIDE

Cardiac Rhythm Alteration [PE]; Antiarrhythmic [EPC]; Adrenergic beta-Antagonists [MoA]

SOTALOL HYDROCHLORIDE TABLES AF

Adrenergic beta-Antagonists [MoA]; Antiarrhythmic [EPC]; Cardiac Rhythm Alteration [PE]

SOTALOL HYDROCHLORIDE TABLETS AF

Antiarrhythmic [EPC]; Adrenergic beta-Antagonists [MoA]; Cardiac Rhythm Alteration [PE]

MeSH Pharmacological Classification · 3 件

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

応用分野 · 2 件

説明Sotalol is a non-selective antagonist of β-adrenergic receptors (β-ARs; IC50s = 8.9 and 5.2 μM for β1- and β2-ARs, respectively) and a class III antiarrhythmic agent. It decreases delayed outward potassium currents (IK) in guinea pig ventricular cells and prolongs action potential duration in electrically stimulated isolated guinea pig papillary muscles when used at a concentration of 100 μM. Sotalol decreases heart rate and increases blood pressure and the cardiac functional refractory period (FRP) in a canine model of ventricular tachycardia induced by programmed electrical stimulation (PES). Formulations containing sotalol have been used in the treatment of ventricular arrhythmias and maintenance of normal sinus rhythm in patients with atrial fibrillation or flutter (AFIB/AFL).

使用Sotalol hydrochloride is used as a potent beta adrenergic antagonist, prolongs the action potential and increases the refractory period. Sotalol hydrochloride is also considered a non-selective β blocker and a potassium channel blocker with an IC50 of 43 μM.

上流・下流製品情報

上流原料

塩酸
補足説明 · 1 件

定義ChEBI: A hydrochloride salt that is the monohydrochloride of sotalol. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

関連反応

4 件
反応記録を作成
HRID 479264 の反応式
HRID 479264反応物として
HRID 651496 の反応式
HRID 651496反応物として
HRID 1534563 の反応式
HRID 1534563反応物として
HRID 2301241 の反応式
HRID 2301241反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート